Quick Answer
STANDARD BIOTOOLS INC. reported Net Income Loss of -$74.90 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed an increase of +46.1% in Net Income Loss from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), STANDARD BIOTOOLS INC.'s Net Income Loss has declined by 291.6%.
- Historical annual values: Fiscal year 2025: -$74.90 million | Fiscal year 2024: -$138.89 million | Fiscal year 2023: -$74.66 million | Fiscal year 2022: -$190.10 million | Fiscal year 2021: -$59.24 million | Fiscal year 2020: -$53.02 million | Fiscal year 2019: -$64.79 million | Fiscal year 2018: -$59.01 million | Fiscal year 2017: -$60.54 million | Fiscal year 2016: -$75.99 million | Fiscal year 2015: -$53.32 million | Fiscal year 2014: -$52.83 million | Fiscal year 2013: -$16.53 million | Fiscal year 2012: -$19.02 million | Fiscal year 2011: -$22.47 million | Fiscal year 2010: -$16.90 million | Fiscal year 2009: -$19.13 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: